# To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With Endometriosis

> **NCT02425462** · — · COMPLETED · sponsor: **Bayer** · enrollment: 895 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Dienogest (Visanne, BAY86-5258)

## Key facts

- **NCT ID:** NCT02425462
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-28
- **Primary completion:** 2018-09-28
- **Final completion:** 2018-12-14
- **Target enrollment:** 895 (ACTUAL)
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02425462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02425462, "To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With Endometriosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02425462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*